| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/29/2026 | ±3.3% | -3.1% | over-priced |
| 04/29/2026 | ±3.7% | -1.2% | over-priced |
| 02/18/2026 | ±2.5% | -1.1% | over-priced |
| 10/30/2025 | ±2.4% | +0.6% | over-priced |
| 07/31/2025 | ±2.3% | -0.2% | over-priced |
| 05/01/2025 | ±4.2% | -0.5% | over-priced |
| 02/19/2025 | ±2.1% | +0.6% | over-priced |
| 10/30/2024 | ±1.9% | -1.7% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.43 | $7.5B | $752M |
| Q1 FY2026 | $1.15 | $6.8B | $605M |
| Q4 FY2025 | — | $6.8B | $557M |
| Q3 FY2025 | $1.12 | $6.7B | $590M |
PACCAR Inc. Common Stock (PCAR) reports imminently, with the next report estimated for 10/27/2026. Across the last 8 reports, options priced an average ±2.8% earnings move while the stock actually moved 1.1% on average — the market has systematically over-priced PCAR's earnings risk. Fundamentals into the print: EPS up 4.4% year-over-year, revenue up 0.5%. QuantLogix's live 5-factor engine currently reads PCAR as a underweight at 23/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →